We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AZYO market cap is 54.27M. The company's latest EPS is USD -1.4812 and P/E is -1.01.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.88M | 6.69M | 6.29M | 5.92M | 5.47M |
| Operating Income | -8.51M | -8.48M | -8.51M | -10.23M | -8.43M |
| Net Income | -9.31M | -17.99M | -28.18M | 1.29M | -9.06M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 42.68M | 47.39M | 49.19M | 24.75M | 24.38M |
| Operating Income | -13.6M | -23.03M | -31.74M | -30.53M | -35.65M |
| Net Income | -25.34M | -24.83M | -32.9M | -37.66M | -53.95M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 43.43M | 35.36M | 41.9M | 48.41M | 36.13M |
| Total Liabilities | 82.03M | 85.66M | 106.24M | 88.65M | 82.39M |
| Total Equity | -38.6M | -50.3M | -64.34M | -40.24M | -46.26M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 82.81M | 67.17M | 68.84M | 43.43M | 36.13M |
| Total Liabilities | 61.98M | 53.65M | 73.87M | 82.03M | 82.39M |
| Total Equity | 20.83M | 13.52M | -5.03M | -38.6M | -46.26M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.76M | -2.64M | -6.97M | -10.4M | -22.66M |
| Investing | 14.21M | -15k | 167k | -380k | -474k |
| Financing | 9.84M | -4.07M | 5.72M | 17.25M | 17.09M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.63M | -15.45M | -21.43M | -21.76M | -22.66M |
| Investing | -640k | -369k | -540k | 14.21M | -474k |
| Financing | 51.21M | 6.71M | 8.54M | 9.84M | 17.09M |
| Market Cap | 54.27M |
| Price to Earnings Ratio | -1.01 |
| Price to Sales Ratio | 2.23 |
| Price to Cash Ratio | 4.1 |
| Price to Book Ratio | -1.17 |
| Dividend Yield | - |
| Shares Outstanding | 36.42M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (2.61%) |
| Company Name | Aziyo Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.elutia.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
